Intradermal tranexamic acid injections to prevent post-inflammatory hyperpigmentation after solar lentigo removal with a Q-switched 532-nm Nd:YAG laser

References

• Ezzedine K, Mauger E, Latreille J, Jdid R, Malvy D, Gruber F, et al. Freckles and solar lentigines have different risk factors in Caucasian women. J Eur Acad Venereol. 2013;27(3):e345–e56.
   PubMed Web of Science ®Google Scholar
• Ortonne JP, Pandya AG, Lui H, Hexsel D. Treatment of solar lentigines. J Am Acad Dermatol. 2006;54(5 Suppl 2):S262–71.
   PubMed Web of Science ®Google Scholar
• Negishi K, Akita H, Tanaka S, Yokoyama Y, Wakamatsu S, Matsunaga K. Comparative study of treatment efficacy and the incidence of post-inflammatory hyperpigmentation with different degrees of irradiation using two different quality-switched lasers for removing solar lentigines on Asian skin. J Eur Acad Venereol. 2013;27(3):307–12.
   PubMed Web of Science ®Google Scholar
• Lacz NL, Vafaie J, Kihiczak NI, Schwartz RA. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol. 2004;43:362–65.
   PubMed Web of Science ®Google Scholar
• Callender VD, St Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011;12(2):87–99.
   PubMed Web of Science ®Google Scholar
• Jimenez PA, Jimenez SE. Tissue and cellular approaches to wound repair. Am J Surg. 2004;187(5A):56S–64S.
   PubMed Web of Science ®Google Scholar
• Tomita Y, Maeda K, Tagami H. Melanocyte stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res. 1992;5(5):357–61.
   PubMedGoogle Scholar
• Ortonne JP. Retinoic acid and pigment cells: a review of in-vitro and in-vivo studies. Br J Dermatol. 1992;127(Suppl 41):43–47.
   PubMedGoogle Scholar
• Taylor S, Grimes P, Lim J, Im S, Lui H. Postinflammatory hyperpigmentation. J Cutan Med Surg. 2009;13(4):183–91.
   PubMed Web of Science ®Google Scholar
• Ortonne JP, Bissett DL. Latest insights into skin hyperpigmentation. J Investig Dermatol Symp Proc. 2008;13(1):10–14.
   PubMedGoogle Scholar
• Cardinali G, Kovacs D, Picardo M. Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo. Ann Dermatol Venereol. 2012;139(Suppl 4):S148–52.
   PubMedGoogle Scholar
• Sriwiriyanont P, Ohuchi A, Hachiya A, Visscher MO, Boissy RE. Interaction between stem cell factor and endothelin-1: effects on melanogenesis in human skin xenografts. Lab Invest. 2006;86(11):1115–25.
   PubMed Web of Science ®Google Scholar
• Kim JS, Nam CS, Kim JY, Gye JW, Hong SP, Kim MH, et al. Objective evaluation of the effect of Q-Switched Nd: YAG (532 nm) laser on solar lentigo by using a colorimeter. Ann Dermatol. 2015;27(3):326–28.
   PubMed Web of Science ®Google Scholar
• Todd MM, Rallis TM, Gerwels JW, Hata TR. A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial. Arch Dermatol. 2000;136(7):841–46.
   PubMedGoogle Scholar
• Vachiramon V, Panmanee W, Techapichetvanich T, Chanprapaph K. Comparison of Q-switched Nd: YAG laser and fractional carbon dioxide laser for the treatment of solar lentigines in Asians. Lasers Surg Med. 2016;48(4):354–59.
   PubMed Web of Science ®Google Scholar
• Cheyasak N, Manuskiatti W, Maneeprasopchoke P, Wanitphakdeedecha R. Topical corticosteroids minimise the risk of postinflammatory hyperpigmentation after ablative fractional CO2 laser resurfacing in Asains. Acta Derm Venereol. 2015;95(2):201–05.
   PubMed Web of Science ®Google Scholar
• Nakano T, Fujita H, Kikuchi N, Arita H. Plasmin converts pro-form of group I phospholipase A2 into receptor binding, active forms. Biochem Bioph Res Co. 1994;198(1):10–15.
   PubMed Web of Science ®Google Scholar
• Chung JY, Lee JH, Lee JH. Topical tranexamic acid as an adjuvant treatment in melasma: side-by-side comparison clinical study. J Dermatolog Treat. 2016;27(4):373–77.
   PubMed Web of Science ®Google Scholar
• Cho HH, Choi M, Cho S, Lee JH. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd: YAG laser. J Dermatolog Treat. 2013;24(4):292–96.
   PubMed Web of Science ®Google Scholar
• Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, et al. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg. 2006;32(5):626–31.
   PubMed Web of Science ®Google Scholar
• West TB, Alster TS. Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing. Dermatol Surg. 1999;25(1):15–17.
   PubMed Web of Science ®Google Scholar
• Uaboonkul T, Nakakes A, Ayuthaya PK. A randomized control study of the prevention of hyperpigmentation post Q-switched Nd: YAG laser treatment of Hori nevus using topical fucidic acid plus betamethasone valerate cream versus fucidic acid cream. J Cosmet Laser Ther. 2012;14(3):145–49.
   PubMed Web of Science ®Google Scholar
• Park GH, Rhee Do Y, Moon HR, Won Ch, Lee MW, Choi JH, et al. Effect of an epidermal growth factor-containing cream on postinflammatory hyperpigmentation after Q-switched 532-nm neodymium-doped yttrium aluminum garnet laser treatment. Dermatol Surg. 2015;41(1):131–35.
   PubMed Web of Science ®Google Scholar
• Chan NP, Ho SG, Yeung CK, Shek SY, Chan HH. Fractional ablative carbon dioxide laser resurfacing for skin rejuvenation and acne scars in Asians. Lasers Surg Med. 2010;42(9):615–23.
   PubMed Web of Science ®Google Scholar
• Kato H, Araki J, Eto H, Doi K, Hirai R, Kuno S, et al. A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyperpigmentation after Q-switched ruby laser. Dermatol Surg. 2011;37(5):605–10.
   PubMed Web of Science ®Google Scholar
• US FDA. Cyklokapron. 2011 [accessed 2017 Jan 15]. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019281s030lbl.pdf.
   Google Scholar
• Kang HJ, Na JI, Lee JH, Roh MR, Ko JY, Chang SE. Postinflammatory hyperpigmentation associated with treatment of solar lentigines using a Q-Switched 532-nm Nd: YAG laser: a multicenter survey. J Dermatolog Treat. 2016:1–5.
   PubMed Web of Science ®Google Scholar
• Steiner D, Feola C, Bialeski N, Antiori A, Folino BB, Addor F, et al. Study evaluating the efficacy of topical and injected tranexamic acid in treatment of melasma. Surg Cosmet Dermatol. 2009;1(4):174–77.
   Google Scholar
• Elfar NN, El-Maghraby GM. Efficacy of intradermal injection of tranexamic acid, topical silymarin and glycolic acid peeling in treatment of melasma: a comparative study. J Clin Exp Dermatol Res. 2015;6(3):1–7.
   Google Scholar
• Angchaisuksiri P, Aryuchai K, Thanasarnaksorn W, Tantibhaedhyangkul V, et al. Fibrinolytic activity, thrombin generation and the safety during long term treatment with tranexamic acid in Thai patients with melasma. Blood. 2001 Nov;98(11):3977.
   Web of Science ®Google Scholar